Skip to main content
Medpace Holdings, Inc. logo

Medpace Holdings, Inc. — Investor Relations & Filings

Ticker · MEDP ISIN · US58506Q1094 LEI · 549300H8TYEUVTW14A54 US Professional, scientific and technical activities
Open in API
Filings indexed 858 across all filing types
Latest filing 2022-02-17 Director's Dealing
Country US United States of America
Listing US MEDP

About Medpace Holdings, Inc.

https://investor.medpace.com/

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO) that provides Phase I-IV clinical development services. The company serves the biotechnology, pharmaceutical, and medical device industries, with a mission to accelerate the development of safe and effective medical therapeutics. Medpace employs a disciplined operating approach that leverages regulatory and therapeutic expertise. Its services include clinical pharmacology, central laboratory, bioanalytical, ECG core lab, and imaging core labs. The company has expertise across major therapeutic areas, including oncology, cardiology, metabolic disease, endocrinology, central nervous system, and anti-viral and anti-infective diseases.

Recent filings

Filing Released Lang Actions
FORM 4
Director's Dealing
2022-02-17 English
10-K
Annual Report FY 2021
2022-02-15 English
8-K
Capital/Financing Update Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The text includes an announcement of financial results via a press release (not the full financial report itself), and an increase in the stock repurchase program. The document length is 4324 characters, which is relatively short and mainly contains announcements rather than detailed financial statements or analysis. The key items are "Results of Operations and Financial Condition" announced via press release and an "Other Event" about stock repurchase program increase. This fits the category of Capital/Financing Update (CAP) because it includes a significant update on the company's stock repurchase program, which is a capital structure activity. The financial results announcement is referenced but not the full report itself, so it is not an Earnings Release (ER) or Interim Report (IR). Therefore, the best classification is CAP with high confidence.
2022-02-14 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-02-10 English
SCHEDULE 13G/A
Major Shareholding Notification
2022-02-10 English
Major Shareholding Notification 2022
Major Shareholding Notification
2022-01-27 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.